← Back
$LXEO All transactions

Lexeo Therapeutics, Inc.

A

$ Value

$0

Shares

280,000

Price

$0

Filed

Sep 3

Insider

Name

Tamayo Louis Edward

Title

Chief Financial Officer

CIK

0002083206

Roles

Officer

Transaction Details

Transaction Date

2025-08-29

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

280,000

Footnotes

The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on August 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date. | The reported securities are RSUs. | 25% of the shares underlying the option vest and become exercisable on August 15, 2026, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

Filing Info

Accession No.

0001415889-25-023491

Form Type

4

Issuer CIK

0001907108

Tamayo Louis Edward's History

Date Ticker Type Value
2025-08-29 LXEO A $0
2025-08-29 LXEO A $0

Other Insiders at LXEO (90d)

Insider Bought Sold Last
Townsend Richard Nolan
Chief Executive Officer
$313K 2026-04-06